why choose us

Clinical Trials Search

Showing 16,610 of 132,963 result(s)
Titanium vs. PEEK Fusion Devices in 1 Level TLIF

Status: NOT_YET_RECRUITING

Condition: Spine Fusion

Interventions: Titanium fusion device will be utilized for one-level lumbar fusion.

Date: 2023-01-09

Prospective Study Evaluating the Clinical Tolerance of Skin Tattoos During MRI Examinations (TATOU - IRM)

Status: Completed

Condition: Tattoo Disorder

Interventions: Patient with a tatoo will perform an MRI.
The possible symptoms during the MRI or after MRI will then be described (duration, type,...).

Date: 2023-01-09

LYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS)

Status: COMPLETED

Condition: Breast Cancer

Interventions:

Date: 2023-01-09

Feasibility of Positive Links for Youth Care Engagement Intervention

Status: COMPLETED

Condition: HIV Antibody Positivity

Interventions: A mobile app provided to participants to assess effectiveness in managing HIV

Date: 2023-01-09

Regional Anesthesia Following Pediatric Cardiac Surgery

Status: COMPLETED

Condition: Atrial Septal Defect

Interventions: Bilateral pecto-intercostal fascial plane block (PIFB) and unilateral rectus sheath block (RSB) with Ropivacaine 0.2%

Date: 2023-01-09

The Effect of Sugar Load in IBS Patients Depending on Sucrase-isomaltase Genes

Status: COMPLETED

Condition: Sucrase-Isomaltase Deficiency

Interventions: 75 g sugar dissolved in 0.8 dl water and flavored with lemon.
Ingested during 5 minutes

Date: 2023-01-09

The Effect of Sugar Load in IBS Patients Depending on Sucrase-isomaltase Genes

Status: COMPLETED

Condition: Sucrase-Isomaltase Deficiency

Interventions: 75 g sugar dissolved in 0.8 dl water and flavored with lemon.
Ingested during 5 minutes

Date: 2023-01-09

A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination With Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors

Status: COMPLETED

Condition: Solid Tumor, Adult

Interventions: DRUG: IOS-1002 - monotherapy
DRUG: IOS-1002 + KEYTRUDA® (pembrolizumab) - combination therapy

Date: 2023-01-09

Postural Changes and Severe COVID-19

Status: Completed

Condition: COVID-19

Interventions: The main difference between the intervention group and the control group was the position during oxygen therapy.
Patients in the intervention gro

Date: 2023-01-08

The Effectiveness of Eating Disorder Treatment

Status: Completed

Condition: Eating Disorders

Interventions: Interventional

Date: 2023-01-08